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case report
A 29-year-old male patient presented at the Oral Medicine 
Clinic with the complaint of slow-growing growths on his 
tongue, causing discomfort. Extra-oral examination revealed 
several painless soft tissue nodules on his face (Figure 1 
and 2), trunk (Figure 3), back (Figure 4) and arms. The pa-
tient reported that the lesions had appeared during child-
hood and had since increased in size and number. He was 
unaware of any family history of the disease. intra-oral ex-
amination showed two soft tissue nodules on the midline 
of the dorsal surface of the tongue, 3,5cm and 0,5 cm in 
diameter respectively (Figure 5).
An excisional biopsy of the smaller nodule was performed 
and the specimen submitted for histopathological evalua-
tion. A 0.2% aqueous solution of chlorhexidine digluconate 
was prescribed as antibacterial mouthwash. The patient 
was instructed on the management of possible postopera-
tive bleeding and asked to return to the clinic a week later 
for suture removal.
 
dIagnosIs and ManageMent
Histological examination revealed an ill-defined benign cel-
lular neoplasm consisting of bland short fusiform or rounded 
Schwann cells in a fine fibrillary collagenous background. The 
lesion exhibited an infiltrative growth, with extension along the 
connective tissue septa and between fat cells and skeletal 
muscle fibres (Figures 6 and 7). The lesional Schwann cells 
stained positively for S-100 protein (Figure 8). The histopatho-
logical diagnosis of an incompletely excised neurofibroma (dif-
fuse type), together with the characteristic clinical features and 
history, led to a final clinical diagnosis of neurofibromatosis.1
 
At the next visit the diagnosis was conveyed to the patient 
and he was referred to the Department of Oral and Maxil- lofacial Surgery for the removal of the residual tongue le-
sions, and the Dermatology Clinic for further investigation 
and management of the skin lesions.
dIscussIon
Neurofibromas are fairly common, benign neoplasms of 
peripheral nerves, usually presenting as solitary lesions of 
the skin, mostly on the head and neck but occasionally on 
mucosal surfaces. Localised or solitary neurofibromas are 
often seen in patients who are otherwise healthy. A diagno-
sis of neurofibromatosis type 1 (NF1) should be considered 
if a patient presents with oral mucosal neurofibromas and 
concomitant multiple skin lesions. NF1 is the most com-
mon form of neurofibromatosis and is also known as von 
Recklinghausen’s disease, eponymously named after a 19th 
century German pathologist (1833-1910). NF1 is a reason-
ably common, dominantly inherited condition with high pen-
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figure 1: The patient presented with multiple nodules on the forehead and 
around the eye.
figure 2: A large nodule and several smaller ones were present on the left pre-
auricular region. 
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etrance and variable expression. Several different clinical 
variants of the disorder have been described. The condition 
is caused by a defect in a large gene on chromosome 17 
that expresses a tumour suppressor protein, Neurofibromin 
1, which inactivates the Ras oncogene. The loss of NF1 
gene expression therefore results in increased Ras activ-
ity, cell proliferation and uncontrolled growth of cells of the 
neural crest, i.e. Schwann cells, melanocytes and endoneu-
rial fibroblasts. The resultant uncontrolled growth produces 
tumours throughout the body together with disorders of 
skin pigmentation, including the development of café-au-lait 
spots. The Neurofibromin 1 gene is a large gene with many 
homologous regions and is thus predisposed to developing 
mutations. Neurofibromatosis type 1 affects approximately 
one in every 3000 individuals in many populations world-
wide. Only half of the patients with this disease have af-
fected family members with the remaining 50% of cases of 
NF1 arising from de novo germ-cell mutations.1, 4
A diagnosis of NF1 can be made when two or more of the 
following clinical features are present: six or more café-
au-lait macules, axillary or inguinal freckling, two or more 
neurofibromas of any type or one plexiform neurofibroma, 
optic glioma, two or more Lisch nodules (iris hamartomas), 
a distinct osseous lesion such as sphenoid dysplasia or 
pseudoarthrosis or thinning of the long bone cortex, and a 
first-degree relative with NF1 by the above criteria.1, 2 Neu-
rofibromatosis type 2 (NF2) is another variant of neurofi-
bromatosis and is the result of a mutation in the NF2 gene 
on chromosome 22. The main feature of this condition is 
bilateral schwannomas affecting the eighth cranial nerve. it 
is estimated that the condition affects one in every 25000 
individuals worldwide.2
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figure 3: Multiple cutaneous and subcutaneous nodules were present on the 
trunk and arms of the patient.
figure 4: A large number of cutaneous and subcutaneous nodules were 
present on the back and arms of the patient. Note the large growth on the 
patient’s right shoulder.
figure 5: Two soft tissue nodules covered by normal oral mucosa were present 
on the dorsal surface of the tongue. Unlike the smaller nodule, the larger nodule is 
raised with well-defined borders.
figure 6: This photomicrograph illustrates a nodule covered by parakeratinising 
stratified squamous epithelium (H & E, x40).
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Studies indicate that oral lesions are present in approximate-
ly 75% of all cases of NF1 and there is a strong associa-
tion between NF1 and tongue neurofibromas.1,4 Neurofibro-
mas commonly affect young adults and initially present as 
slow-growing, soft, painless lesions that vary in size from 
small nodules to substantial tissue masses.4 Commonly af-
fected intra-oral sites include the tongue, buccal mucosa, 
alveolar ridge, gingivae, lips, palate, floor of mouth and the 
pharyngomaxillary space.2 The majority of lesions affecting 
the tongue are nodular in nature but, at times may present 
as macroglossia. Symptoms associated with tongue lesions 
include discomfort and pain. if the base of the tongue is 
involved, it may also include odynophagia, dysphagia, voice 
changes and otalgia. The presence of a neck mass, tooth 
loss or impacted and malpositioned teeth are other signs 
frequently encountered in these cases.1
Pathologically, several types of neurofibroma occur with 
NF1. They are distinguished on the basis of their gross and 
microscopic features and include: localised neurofibroma, 
plexiform neurofibroma, diffuse neurofibroma and pigment-
ed neurofibroma. A feature unique to all neurofibromas is the 
presence of Schwann cells in a fibrous to myxoid stroma. 
Diffuse neurofibroma is ill-defined and spreads between 
connective tissue elements (fat cells and skeletal muscle 
fibres). Despite its infiltrative growth, it does not destroy but 
rather envelops the native tissue structures.
The differential clinical diagnosis of a solitary neurofibroma in-
cludes other submucosal masses of connective tissue origin 
such as traumatic fibroma, granular cell tumour and lipoma. 
if a diffuse lesion is present, resulting in macroglossia, the 
differential diagnosis should also include lymphangioma and 
amyloidosis.5 Solitary neurofibromas usually run a benign clin-
ical course with a low frequency of recurrence after surgical 
removal, however, the multiple and larger lesions commonly 
found in NF1, have a higher recurrence rate. Currently there is 
no specific therapy for NF1. Although lesions can be removed 
surgically, the presence of numerous larger lesions may make 
this approach impractical.3,4,5 Extensive facial lesions that 
need to be removed for cosmetic reasons usually respond 
well to carbon dioxide laser ablation or dermabrasion.4
Malignant transformation of neurofibromas may occur but 
the incidence of this complication is low with only 2%-6% 
of patients with NF1 developing malignancies. This associa-
tion is however, greater with plexiform neurofibromas. The 
development of malignant peripheral nerve sheath tumour is 
reported to be the leading cause of cancer-related deaths 
in patients with NF1, with a 5-year survival rate of 15%.1, 4 
A sudden increase in the size or appearance of a neurofi-
broma should alert the attending clinician to the possibility 
of malignant transformation.1
conclusIon
The case presented above is typical of NF1, both in terms of 
its clinical presentation and histopathological features. NF1 
is often a dominantly inherited condition but since the patient 
had no family history of NFi, it can be assumed that he was 
one of the approximately 50% of cases where the condition 
is the result of a de novo germ cell mutation. Patients with 
NF1 should be counselled by an appropriately-trained pro-
fessional, particularly if the patient is still in his or her produc-
tive years. it should also be kept in mind that oral mucosal 
neurofibromas may cause discomfort and, when enlarged, 
may interfere with speech and mastication. For that reason, 
symptomatic oral lesions are diagnosed more regularly than 
early painless lesions and clinicians should include neurofi-
bromas in the differential diagnosis when investigating any 
oral mucosal nodules. Histopathological and immunohisto-
chemical evaluation will make an early diagnosis possible 
and could be of immense benefit to a person suffering from 
this potentially debilitating condition.
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figure 7: This photomicrograph shows infiltration of skeletal muscle fibres by a 
cellular neoplasm composed of short fusiform or rounded Schwann cells with 
darkly-stained nuclei in a collagenous background ( H & E, x200). 
figure 8: This photomicrograph shows the positive brown staining for S100 pro-
tein in the lesional Schwann cells (x 400).
